Spots Global Cancer Trial Database for Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Official Title: Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
Study ID: NCT01015274
Conditions
Interventions
Study Description
Brief Summary: The long-term objective of this research is to develop a non-invasive approach for early assessment of which patients are at high risk for future development of skeletal muscle atrophy. The investigators hypothesize that the rate constant for the terminal portion of the isotope decay curve following ingestion of a single oral dose of deuterated-3-methylhistidine (D-3MH) provides an accurate measure of this increased risk and that this rate constant can be measured non-invasively from timed spot urine samples.
Detailed Description:
Keywords
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
University of Texas Medical Branch, Galveston, Texas, United States
Contact Details
Name: Morteza Janghorbani, Ph.D.
Affiliation: BIOCHEMANALYSIS CORPORATION
Role: PRINCIPAL_INVESTIGATOR
Name: Melinda Sheffield-Moore, Ph.D.
Affiliation: University of Texas
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
